OTCMKTS:MSACU Medicus Sciences Acquisition (MSACU) Stock Price, News & Analysis → Is Tesla going out of business? (From DTI) (Ad) Free MSACU Stock Alerts $10.10 -0.16 (-1.56%) (As of 04/6/2021) Add Compare Share Share Today's Range$9.98▼$10.1050-Day Range$10.10▼$10.1052-Week Range$9.50▼$10.64Volume152,100 shsAverage Volume51,570 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Medicus Sciences Acquisition alerts: Email Address Ad Stansberry ResearchControversial CEO explains new way to amass wealthThere's no shortage of controversial CEOs in America today... From Elon Musk... to Disney's Bob Iger... to JP Morgan's Jamie Dimon... But only one controversial CEO that I know of is willing to show you exactly how and why he cut his annual salary to $1...Don't miss Porter's brand-new presentation on this subject About Medicus Sciences AcquisitionMedicus Sciences Acquisition Corp. operates as blank check company targeting the medical technology sector. The company was incorporated in 2020 and is based in New York, New York.Read More MSACU Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MSACU Stock News HeadlinesNo headlines for this company have been tracked by MarketBeat.com Receive MSACU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medicus Sciences Acquisition and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorFinance Industry Shell Companies Sub-IndustryN/A Current SymbolOTCMKTS:MSACU CUSIPN/A CIKN/A WebN/A Phone212 259 8400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesDr. Jacob Jay Gottlieb C.F.A. (Age 49)CFA, M.D., Exec. Chairman Dr. Michael Bernard Castor M.D. (Age 49)CEO & Director Dr. Judah Zvi Drillick CPA (Age 44)Chief Financial Officer Mr. Eric B. Cheng (Age 51)Chief Bus. Officer Key Competitors10X Capital Venture AcquisitionOTCMKTS:VCVCU890 5th Avenue PartnersOTCMKTS:ENFAUACE Convergence AcquisitionOTCMKTS:ACEVUACON S2 AcquisitionOTCMKTS:STWOUAlpha Capital AcquisitionOTCMKTS:ASPCUView All Competitors MSACU Stock Analysis - Frequently Asked Questions How have MSACU shares performed in 2024? Medicus Sciences Acquisition's stock was trading at $10.10 at the start of the year. Since then, MSACU stock has increased by 0.0% and is now trading at $10.10. View the best growth stocks for 2024 here. How do I buy shares of Medicus Sciences Acquisition? Shares of MSACU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MSACU) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm PressThe 2024 crypto bull run has already started — don’t get left behindInvestorPlaceThe asset beating inflation by 4xColonial MetalsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldCould Your Accounts Be Frozen?Allegiance GoldHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medicus Sciences Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.